共 50 条
- [31] Safety, phase I/II study with intrathecal and intravenous injection of mesenchymal stem cells in patients with multiple sclerosis and amyotrophic lateral sclerosisMULTIPLE SCLEROSIS, 2008, 14 : S21 - S21Karussis, DimitriosKarageorgiou, ClementineGowda-Kurkalli, BasanVaknin-Dembinsky, AdiKassis, IbrahimGkortzolidis, GeorgePapageorgiou, HelenStavropoulou, EkateriniPetrou, PanayiotaBen-Hur, TamirSlavin, Shimon
- [32] SAFETY AND EFFICACY OF INTRAVENOUS ADMINISTRATION OF BONE-MARROW DERIVED MESENCHYMAL STROMAL CELLS IN THERAPY REFRACTORY JUVENILE IDIOPATHIC ARTHRITIS PATIENTS, A PHASE IB/IIA PILOT-STUDYANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 150 - 151Swart, J. F.de Roock, S.Nievelstein, R. J.Slaper-Cortenbach, I.Boelens, J. J.Wulffraat, N.
- [33] A phase I/II multi-center study of Troxatyl™ in patients with refractory chronic lymphocytic leukemia (CLL), lymphoma or multiple myeloma (MM).BLOOD, 2001, 98 (11) : 289B - 289BGiles, FBelanger, RToor, AMcLaughlin, PFayad, LBeran, MAlbitar, MVose, J
- [34] An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report.JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 346S - 346SChao, YLi, CPChao, TYSu, WCHsieh, RKWu, MFYeh, KHChen, LTCheng, AL
- [35] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 studyANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)Mei, HengChen, XiequnZhou, JianfengLuo, JianminShi, QingzhiLiu, JingWu, DepeiChen, GuoanTai, YanfeiXiong, JunyeZou, JianjunHu, Yu
- [36] A prospective, randomized, controlled, double-blind, multi-center study to evaluate the efficacy and safety of a blue light device for the treatment of chronic back painFRONTIERS IN PAIN RESEARCH, 2024, 5Baron, RalfMorlion, BartDahan, AlbertUeberall, Michaelvon Basum, GoloWild, Imane
- [37] A Multi-Center, Open Label, Phase I/II Study to Assess the Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell LymphomaBLOOD, 2020, 136Iyer, Swami P.Huen, AurisHaverkos, BradleyAi, Weiyun Z.Okada, CraigKuzel, Timothy M.Lechowicz, Mary JoAlderuccio, Juan PabloMohrbacher, AnnStevens, Don A.Wilcox, Ryan A.Feldman, Tatyana A.Sundaram, SuchitraJagadeesh, DeepaReddy, NishithaRouthu, Kasi ViswanathBarde, PrajakNair, Ajit Mohanchandran
- [38] Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a studyJOURNAL OF NEUROSURGERY, 2019, 131 (05) : 1462 - 1472Steinberg, Gary K.Kondziolka, DouglasWechsler, Lawrence R.Lunsford, L. DadeKim, Anthony S.Johnson, Jeremiah N.Bates, DamienPoggio, GeneCase, CaseyMcGrogan, MichaelYankee, Ernest W.Schwartz, Neil E.
- [39] A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)BLOOD, 2022, 140 : 4570 - 4572Perez, AntonioFerreras, CristinaHernandez, ClaraMartin-Quiros, AlejandroAl-Akioui, KarimaMora-Rillo, MartaIbanez, FatimaGoterris, RosaDe Paz Arias, RaquelGuerra-Garcia, PilarQueiruga-Parada, JavierMolina, PabloBou, MercheMestre-Duran, CarmenBorobia, AlbertoCarcas, Antonio J.Luisa Briones, MariaLuis Vicario, JoseAngel Moreno, MiguelBalas, AntonioEguizabal, CristinaSoria, BernatSolano, Carlos
- [40] Safety of stereotactic intracranial injection of modified bone marrow-derived mesenchymal stem cells (SB623) in chronic stroke patients: A Phase 1/2A studyINTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 88 - 88Steinberg, G. K.Kondziolka, D.Wechsler, L.Lunsford, L. D.Kim, A. S.Johnson, J. N.Bates, D.McGrogan, M.Yankee, E. W.Schwartz, N. E.